Previous studies have proved that activation of IDO and high QA expression were found in an animal model of depression, and treatment with an IDO inhibitor prevented the development of inflammation-induced depressive-like behaviors in rodents [21–23]. This evidence concerns the gene IDO1 and depressive symptom measurement.